Skip to main content
Gut logoLink to Gut
. 1973 May;14(5):360–364. doi: 10.1136/gut.14.5.360

Serum autoantibodies and immunoglobulins in hepatitis-associated antigen (HAA)-positive and -negative liver disease

F J Dudley, M J O'Shea, A Ajdukiewicz, S Sherlock
PMCID: PMC1412696  PMID: 4197747

Abstract

Serum immunoglobulin G, A, and M and serum antinuclear, mitochondrial, and smooth muscle antibody have been measured in 223 patients with hepatitis-associated antigen (HAA)-positive and -negative acute and chronic liver disease. In patients with acute hepatitis, chronic persistent hepatitis, and primary liver cell carcinoma, these indices failed to show any significant differences. However, in the group with chronic aggressive hepatitis the patients who were HAA negative had significantly higher levels of serum IgG, much higher titres of smooth muscle antibody, and often antinuclear and mitochondrial antibodies which were not found in the HAA-positive patients from this group. This suggests that different pathogenic mechanisms may be operative in HAA-positive and -negative chronic aggressive hepatitis.

Full text

PDF
360

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Ajdukiewicz A. B., Fox R. A., Dudley F. J., Doniach D., Sherlock S. Immunological studies in an epidemic of infective, short-incubation hepatitis. Lancet. 1972 Apr 15;1(7755):803–805. doi: 10.1016/s0140-6736(72)90795-7. [DOI] [PubMed] [Google Scholar]
  2. Barreto V. T., Klatskin G. Infectious and serum viral hepatitis: differentiation with serum IgM and thymol turbidity as criteria. JAMA. 1972 Aug 7;221(6):571–575. [PubMed] [Google Scholar]
  3. Blumberg B. S., Gerstley B. J., Hungerford D. A., London W. T., Sutnick A. I. A serum antigen (Australia antigen) in Down's syndrome, leukemia, and hepatitis. Ann Intern Med. 1967 May;66(5):924–931. doi: 10.7326/0003-4819-66-5-924. [DOI] [PubMed] [Google Scholar]
  4. Bulkley B. H., Goldfinger S. E., Heizer W. D., Isselbacher K. J., Shulman N. R. Distinctions in chronic active hepatitis based on circulating hepatitis-associated antigen. Lancet. 1970 Dec 26;2(7687):1323–1326. doi: 10.1016/s0140-6736(70)92356-1. [DOI] [PubMed] [Google Scholar]
  5. Doniach D., Roitt I. M., Walker J. G., Sherlock S. Tissue antibodies in primary biliary cirrhosis, active chronic (lupoid) hepatitis, cryptogenic cirrhosis and other liver diseases and their clinical implications. Clin Exp Immunol. 1966 Jul;1(3):237–262. [PMC free article] [PubMed] [Google Scholar]
  6. FAHEY J. L., MCKELVEY E. M. QUANTITATIVE DETERMINATION OF SERUM IMMUNOGLOBULINS IN ANTIBODY-AGAR PLATES. J Immunol. 1965 Jan;94:84–90. [PubMed] [Google Scholar]
  7. Farrow L. J., Holborow E. J., Johnson G. D., Lamb S. G., Stewart J. S., Taylor P. E., Zuckerman A. J. Autoantibodies and the hepatitis-associated antigen in acute infective hepatitis. Br Med J. 1970 Jun 20;2(5711):693–695. doi: 10.1136/bmj.2.5711.693. [DOI] [PMC free article] [PubMed] [Google Scholar]
  8. Feizi T. Immunoglobulins in chronic liver disease. Gut. 1968 Apr;9(2):193–198. doi: 10.1136/gut.9.2.193. [DOI] [PMC free article] [PubMed] [Google Scholar]
  9. Fox R. A., Niazi S. P., Sherlock S. Hepatitis-associated antigen in chronic liver disease. Lancet. 1969 Sep 20;2(7621):609–612. doi: 10.1016/s0140-6736(69)90324-9. [DOI] [PubMed] [Google Scholar]
  10. Giles J. P., Krugman S. Viral hepatitis. Immunoglobulin response during the course of the disease. JAMA. 1969 Apr 21;208(3):497–503. doi: 10.1001/jama.208.3.497. [DOI] [PubMed] [Google Scholar]
  11. Giles J. P., McCollum R. W., Berndtson L. W., Jr, Krugman S. Relation of Australia-SH antigen to the willowbrook MS-2 strain. N Engl J Med. 1969 Jul 17;281(3):119–122. doi: 10.1056/NEJM196907172810302. [DOI] [PubMed] [Google Scholar]
  12. HOLBOROW J., JOHNSON G. D. ANTINUCLEAR FACTOR IN SYSTEMIC LUPUS ERYTHEMATOSUS. A CONSIDERATION OF THE IMMUNOFLUORESCENT METHOD OF DETECTING ANTINUCLEAR ANTIBODIES, WITH RESULTS OBTAINED IN A FAMILY STUDY. Arthritis Rheum. 1964 Apr;7:119–127. doi: 10.1002/art.1780070204. [DOI] [PubMed] [Google Scholar]
  13. Krugman S., Giles J. P. Viral hepatitis. New light on an old disease. JAMA. 1970 May 11;212(6):1019–1029. doi: 10.1001/jama.212.6.1019. [DOI] [PubMed] [Google Scholar]
  14. Nielsen J. O., Dietrichson O., Elling P., Christoffersen P. Incidence and meaning of persistence of Australia antigen in patients with acute viral hepatitis: development of chronic hepatitis. N Engl J Med. 1971 Nov 18;285(21):1157–1160. doi: 10.1056/NEJM197111182852101. [DOI] [PubMed] [Google Scholar]
  15. Peters C. J., Johnson K. M. Serum immunoglobulin levels in Australia antigen positive and Australia antigen negative hepatitis. Clin Exp Immunol. 1972 Jul;11(3):381–391. [PMC free article] [PubMed] [Google Scholar]
  16. Peters R. L., Ashcavai M. Immunoglobulin levels in detection of viral hepatitis. Am J Clin Pathol. 1970 Jul;54(1):102–109. doi: 10.1093/ajcp/54.1.102. [DOI] [PubMed] [Google Scholar]
  17. Prince A. M. An antigen detected in the blood during the incubation period of serum hepatitis. Proc Natl Acad Sci U S A. 1968 Jul;60(3):814–821. doi: 10.1073/pnas.60.3.814. [DOI] [PMC free article] [PubMed] [Google Scholar]
  18. Prince A. M. Role of serum hepatitis virus in chronic liver disease. Gastroenterology. 1971 May;60(5):913–921. [PubMed] [Google Scholar]
  19. Reinicke V., Dybkjaer E., Poulsen H., Banke O., Lylloff K., Nordenfelt E. A study of Australia-antigen-positive blood donors and their recipients, with special reference to liver histology. N Engl J Med. 1972 Apr 20;286(16):867–870. doi: 10.1056/NEJM197204202861604. [DOI] [PubMed] [Google Scholar]
  20. Sherlock S., Fox R. A., Niazi S. P., Scheuer P. J. Chronic liver disease and primary liver-cell cancer with hepatitis-associated (Australia) antigen in serum. Lancet. 1970 Jun 13;1(7659):1243–1247. doi: 10.1016/s0140-6736(70)91737-x. [DOI] [PubMed] [Google Scholar]
  21. Vischer T. L. Australia antigen and autoantibodies in chronic hepatitis. Br Med J. 1970 Jun 20;2(5711):695–698. doi: 10.1136/bmj.2.5711.695. [DOI] [PMC free article] [PubMed] [Google Scholar]
  22. Whitehouse J. M., Holborow E. J. Smooth muscle antibody in malignant disease. Br Med J. 1971 Nov 27;4(5786):511–513. doi: 10.1136/bmj.4.5786.511. [DOI] [PMC free article] [PubMed] [Google Scholar]
  23. Wright R. Australia antigen and smooth-muscle antibody in acute and chronic hepatitis. Lancet. 1970 Mar 7;1(7645):521–522. doi: 10.1016/S0140-6736(70)91605-3. [DOI] [PMC free article] [PubMed] [Google Scholar]
  24. Wright R., McCollum R. W., Klatskin G. Australia antigen in acute and chronic liver disease. Lancet. 1969 Jul 19;2(7612):117–121. doi: 10.1016/s0140-6736(69)92437-4. [DOI] [PubMed] [Google Scholar]

Articles from Gut are provided here courtesy of BMJ Publishing Group

RESOURCES